Nath Bio-Genes (India) Limited

NATHBIOGEN

Quarterly results

Revenue and net profit

₹ crore

Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.

  • Income
  • ₹ crore

    Jun 2026323

    Quarter₹ croreYoY
    Mar 202443-4.2%
    Jun 2024244+3.7%
    Sept 202432+42.6%
    Dec 202437+16.2%
    Jun 2025280+14.9%
    Sept 202540+23.5%
    Dec 202566+78.9%
    Mar 202646—
    Jun 2026323+15.2%
  • ₹ crore

    Jun 20262

    Quarter₹ crore
    Mar 20240.44
    Jun 20240.14
    Sept 20240.07
    Dec 20240.48
    Jun 20252
    Sept 20252
    Dec 20252
    Mar 20262
    Jun 20262
  • ₹ crore

    Jun 2026325

    Quarter₹ crore
    Mar 202443
    Jun 2024244
    Sept 202432
    Dec 202437
    Jun 2025282
    Sept 202542
    Dec 202568
    Mar 202648
    Jun 2026325
  • Cost structure
  • ₹ crore

    Jun 202610

    Quarter₹ crore
    Mar 20247
    Jun 20246
    Sept 20248
    Dec 202410
    Jun 20259
    Sept 202510
    Dec 202511
    Mar 20263
    Jun 202610
  • ₹ crore

    Jun 2026293

    Quarter₹ crore
    Mar 202441
    Jun 2024210
    Sept 202429
    Dec 202434
    Jun 2025245
    Sept 202537
    Dec 202562
    Mar 202643
    Jun 2026293
  • Exceptional items and tax
  • ₹ crore

    Jun 202633

    Quarter₹ crore
    Mar 20244
    Jun 202434
    Sept 20243
    Dec 20244
    Jun 202539
    Sept 20255
    Dec 20258
    Mar 20266
    Jun 202633
  • ₹ crore

    Jun 20260.72

    Quarter₹ crore
    Mar 20240.62
    Jun 20240.25
    Sept 2024-0.03
    Dec 20241
    Jun 20250.66
    Sept 20250.64
    Dec 20250.87
    Mar 20262
    Jun 20260.72
  • Profit
  • ₹ crore

    Jun 202633

    Quarter₹ croreYoY
    Mar 20243+101.7%
    Jun 202434+1.4%
    Sept 20243+42.1%
    Dec 20243-32.9%
    Jun 202538+12.7%
    Sept 20254+45.4%
    Dec 20257+172.3%
    Mar 20264—
    Jun 202633-14.5%
  • Per share
  • ₹ per share

    Jun 202617.18

    Quarter₹ per share
    Mar 20242.18
    Jun 202417.77
    Sept 20241.46
    Dec 20241.34
    Jun 202520.06
    Sept 20252.16
    Dec 20253.80
    Mar 20262.17
    Jun 202617.18
  • Leverage
  • Debt to equity

    times

    Dec 20250.00x

    Quartertimes
    Mar 2024—
    Jun 2024—
    Sept 2024—
    Dec 2024—
    Jun 2025—
    Sept 2025—
    Dec 20250.00x
    Mar 2026—
    Jun 2026—
₹ croreMar 2024Jun 2024Sept 2024Dec 2024Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Income
432443237280406646323
Revenue YoY-4.2%+3.7%+42.6%+16.2%+14.9%+23.5%+78.9%—+15.2%
0.440.140.070.4822222
432443237282426848325
Cost structure
7681091011310
412102934245376243293
Exceptional items and tax
434343958633
0.620.25-0.0310.660.640.8720.72
Profit
334333847433
Net profit YoY+101.7%+1.4%+42.1%-32.9%+12.7%+45.4%+172.3%—-14.5%
Per share
2.1817.771.461.3420.062.163.802.1717.18
Leverage
Debt to equity——————0.00x——

Latest filed period ends Jun 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.

VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.